Literature DB >> 6718070

Histopathology of the stapes in otosclerosis.

P V Iyer, R E Gristwood.   

Abstract

A histopathological examination was made of 60 stapes obtained during surgery for clinical otosclerosis. The findings, correlated with the clinical history and macroscopic appearances of the stapes, led to the following observations. The histological extent of the focus of otosclerosis agrees well with the macroscopic appearance of the footplate lesion seen under the operating microscope. The earlier the age of onset of hearing loss the greater the probability of active, severe and diffuse otosclerotic involvement of the footplate. Two-thirds of the cases with diffuse and severe footplate otosclerosis had signs of active disease. A late age of onset of clinical otosclerosis tends to be associated with lesions that are limited to the anterior pole of the stapes footplate. Active otosclerosis is rare in these cases. The case for macroscopic increase in extent of the lesion with time could not be established by the data. The evidence supports the view that the severity and extent of otosclerotic disease in the footplate is determined more by age at onset than by duration of symptoms. Healing of the active focus of otosclerosis may not always occur despite a long duration of symptoms. A highly active focus in the stapes footplate can remain active for many years.

Entities:  

Mesh:

Year:  1984        PMID: 6718070     DOI: 10.3109/00313028409067908

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  13 in total

Review 1.  Etiopathogenesis of otosclerosis.

Authors:  Tamás Karosi; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-09       Impact factor: 2.503

2.  Characterization of stapes anatomy: investigation of human and guinea pig.

Authors:  Jae Hoon Sim; Christof Röösli; Michail Chatzimichalis; Albrecht Eiber; Alexander M Huber
Journal:  J Assoc Res Otolaryngol       Date:  2013-01-09

3.  Comparative analysis of preoperative diagnostic values of HRCT and CBCT in patients with histologically diagnosed otosclerotic stapes footplates.

Authors:  Péter Révész; Balázs Liktor; Bálint Liktor; István Sziklai; Imre Gerlinger; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-06       Impact factor: 2.503

4.  Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity.

Authors:  Tamás Karosi; Péter Csomor; Anita Szalmás; József Kónya; Mihály Petkó; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-10-21       Impact factor: 2.503

5.  Diagnostic value of cone-beam CT in histologically confirmed otosclerosis.

Authors:  Balázs Liktor; Péter Révész; Péter Csomor; Imre Gerlinger; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-19       Impact factor: 2.503

Review 6.  An overview of the etiology of otosclerosis.

Authors:  Konstantinos Markou; John Goudakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

7.  Exclusion of TNFRSF11B as Candidate Gene for Otosclerosis in Campania Population.

Authors:  Sandra Iossa; Giovanna Morello; Teresa Esposito; Virginia Corvino; Pasquale Giannini; Raffaella Salvato; Michele Cavaliere; Maria Panetti; Giuseppe Panetti; Bruno Piantedosi; Fernando Gianfrancesco; Elio Marciano; Annamaria Franzè
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-01-30

8.  Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss.

Authors:  István Sziklai; Tamás József Batta; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

9.  Cyclic nucleotide and prostaglandin F2 alpha contents of otosclerotic auditory ossicles.

Authors:  O Ribári; I Sziklai; J G Kiss
Journal:  Arch Otorhinolaryngol       Date:  1985

10.  The effect of flavone treatment on human otosclerotic ossicle organ cultures.

Authors:  I Sziklai; O Ribári
Journal:  Arch Otorhinolaryngol       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.